Search Results 861-870 of 18263 for Lactation

1. A Study Using a New Drug, Nivolumab, in Combination With Chemotherapy Drugs to Treat a Type of Cancer Called Nasopharyngeal Carcinoma (NPC) - Mayo Clinic

   * Lactating females are not eligible unless they have agreed not to breastfeed their infants starting with the first dose of study therapy through 5 months ...

2. Study of Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast Cancer - Mayo Clinic

   - Females who are pregnant or lactating. The participant has previously received treatment with any CDK4 and CDK6 inhibitor. The participant is receiving ...

3. Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study - Mayo Clinic

   Subject is pregnant or lactating, or plans to become pregnant within the study timeframe. Subject has an inability to tolerate bronchoscopy under moderate ...

4. A Study to Evaluate the Effectiveness and Safety of Obeticholic Acid to Treat Patients with Primary Sclerosing Cholangitis - Mayo Clinic

   ... lactating; Other concomitant disease, malignancy, or condition likely to significantly decrease life expectancy to less than the duration of the trial (e.g. ...

5. Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A - Mayo Clinic

   Pregnant or lactating female. Female planning to become pregnant or planning to discontinue contraceptive precautions (if of childbearing potential) before ...

6. A Study to Evaluate the Endorotor® Resection In Refractory Barrett's Dysplasia Patients - Mayo Clinic

   Pregnant or lactating women or women of childbearing potential who do not employ a reliable method of contraception as judged by the Investigator, and/or ...

7. A Study to Investigate the Effectiveness and Safety of Efgartigimod Ph20 SC in Adult Participants with Active Idiopathic Inflammatory Myopathy - Mayo Clinic

   * Participant is pregnant or lactating or intends to become pregnant during the study. * Participant has severe renal impairment . * Participant is ...

8. A Study of Obinutuzumab to Evaluate the Safety and Tolerability in Hypersensitized Adult Participants with End Stage Renal Disease Awaiting Transplantation - Mayo Clinic

   Pregnant or lactating women; Positive serum human chorionic gonadotropin (hCG) measured prior to the first obinutuzumab infusion; Primary or secondary ...

9. Pyridorin in Diabetic Nephropathy - Clinical Trials

   Women who are lactating, pregnant, or intend to become pregnant during the course of the study; Patients who are investigational site staff members and their ...

10. Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Mayo Clinic

    ... lactating at time of enrollment. Note: Other protocol defined Inclusion/Exclusion Criteria may apply. Eligibility last updated 4/14/2025. Questions regarding ...